J7199 HCPCS code: Hemophilia clotting factor, not otherwise classified
J7199 is the HCPCS Level II code for hemophilia clotting factor, not otherwise classified. In 2023 Medicare paid an average of $5.82 per service for J7199 across 763,657 services. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met. In 2023, about 20 clinicians billed Medicare for J7199 for 26 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2000-01-01 |
| Last action effective | 2000-01-01 |
Who bills J7199 (2023)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 20 |
| Medicare beneficiaries | 26 |
| States with claims | 0 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J7199, 2023–2023
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2023 | 763,657 | 26 | $7.30 | $5.82 |
What changed for J7199
- 2000-01-01: J7199 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J7199?
J7199 is the HCPCS Level II code for hemophilia clotting factor, not otherwise classified. Short descriptor: "Hemophilia clot factor noc".
How much does Medicare pay for J7199?
In 2023, the average Medicare payment was $5.82 per service (average allowed $7.30).
Does Medicare cover J7199?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
Related J71 codes
- J7100 — Infusion, dextran 40, 500 ml
- J7110 — Infusion, dextran 75, 500 ml
- J7120 — Ringers lactate infusion, up to 1000 cc
- J7121 — 5% dextrose in lactated ringers infusion, up to 1000 cc
- J7131 — Hypertonic saline solution, 1 ml
- J7165 — Injection, prothrombin complex concentrate, human-lans, per i.u. of factor ix activity
- J7168 — Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity
- J7169 — Injection, coagulation factor xa (recombinant), inactivated-zhzo (andexxa), 10 mg
- J7170 — Injection, emicizumab-kxwh, 0.5 mg
- J7171 — Injection, adamts13, recombinant-krhn, 10 iu
- J7172 — Injection, marstacimab-hncq, 0.5 mg
- J7173 — Injection, concizumab-mtci, 0.5 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J7199
- Watch J7199 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J7199
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.